Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancerKAKOLYRIS, S; KOUROUSSIS, Ch; SOUGLAKOS, J et al.Lung cancer. 2001, Vol 34, pp S71-S76, issn 0169-5002, SUP4Conference Paper

Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) : A phase II trialMAVROUDIS, D; KOUROUSIS, C; SARMONIS, G et al.American journal of clinical oncology. 2000, Vol 23, Num 4, pp 341-344, issn 0277-3732Article

Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy : A multicenter phase II studyANDROULAKIS, N; KOUROUSSIS, C; KOTSAKIS, A et al.Annals of oncology. 1998, Vol 9, Num 10, pp 1127-1130, issn 0923-7534Article

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trialSOUGLAKOS, J; SYRIGOS, K; GEORGOULIAS, V et al.Annals of oncology. 2004, Vol 15, Num 8, pp 1204-1209, issn 0923-7534, 6 p.Article

Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Phase I study of the gemcitbine/oxaliplatin combination in patients with advanced solid tumors : A preliminary reportMAVROUDIS, D; KOUROUSIS, C; KAKOLYRIS, S et al.Seminars in oncology. 2000, Vol 27, Num 1, pp 25-30, issn 0093-7754, SUP2Article

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine : A multicenter phase II trialGEORGOULIAS, V; KOUROUSSIS, C; HATZAKIS, K et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 914-920, issn 0732-183XArticle

Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research GroupPALLIS, A. G; KARAMPEAZIS, A; VAMVAKAS, L et al.Annals of oncology. 2011, Vol 22, Num 11, pp 2448-2455, issn 0923-7534, 8 p.Article

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II studyKAKOLYRIS, S; PAPADAKIS, E; AGELAKI, S et al.Lung cancer. 2001, Vol 32, Num 2, pp 179-187, issn 0169-5002Article

Docetaxel (taxotere) and gemcitabine in the treatment of non-small cell lung cancer : Preliminary resultsGEORGOULIAS, V; KOUROUSIS, C; KOTSAKIS, T et al.Seminars in oncology. 1997, Vol 24, Num 4, pp S14.22-S14.25, issn 0093-7754, SUP14Article

Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: A preliminary report on an active regimenGEORGOULIAS, V; KOUROUSIS, C; HATZIDAKI, D et al.Seminars in oncology. 1997, Vol 24, Num 4, pp S12.61-S12.66, issn 0093-7754, SUP12Conference Paper

A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancerKARACHALIOU, N; KOUROUSSIS, Ch; PAPAKOTOULAS, P et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 5, pp 1345-1352, issn 0344-5704, 8 p.Article

A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumorsKOTSAKIS, A; KOUROUSSIS, Ch; MAVROUDIS, D et al.Oncology. 2006, Vol 71, Num 3-4, pp 190-196, issn 0030-2414, 7 p.Article

A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMAVROUDIS, D; PAPPAS, P; SAMONIS, G et al.Annals of oncology. 2003, Vol 14, Num 2, pp 304-312, issn 0923-7534, 9 p.Article

Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer : A phase II studyKOUROUSSIS, Ch; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 61, Num 1, pp 36-41, issn 0030-2414Article

A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumorsKAKOLYRIS, S; KOUROUSSIS, Ch; SOUGLAKOS, J et al.Oncology. 2001, Vol 61, Num 4, pp 265-270, issn 0030-2414Article

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trialSARIDAKI, Z; ANDROULAKIS, N; SOUGLAKOS, J et al.British journal of cancer. 2012, Vol 107, Num 12, pp 1932-1937, issn 0007-0920, 6 p.Article

Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapySOUGLAKOS, J; KALYKAKI, A; TSETIS, D et al.Annals of oncology. 2007, Vol 18, Num 2, pp 305-310, issn 0923-7534, 6 p.Article

A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumorsKALYKAKI, A; VAMVAKAS, L; GEORGOULIAS, V et al.Oncology. 2006, Vol 71, Num 3-4, pp 197-203, issn 0030-2414, 7 p.Article

Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II studyMAVROUDIS, D; PAVLAKOU, G; MAGKANAS, E et al.Lung cancer. 2003, Vol 39, Num 1, pp 71-76, issn 0169-5002, 6 p.Article

Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: A multicenter phase II trialSOUGLAKOS, J; MAVROUDIS, D; SAMONIS, G et al.Journal of clinical oncology. 2002, Vol 20, Num 11, pp 2651-2657, issn 0732-183XArticle

Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancerKOUROUSSIS, C; ANDROULAKIS, N; VLACHONIKOLIS, J et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 862-869, issn 0732-183XArticle

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancerXENIDIS, N; PERRAKI, M; GEORGOULIAS, V et al.British journal of cancer. 2013, Vol 108, Num 3, pp 549-556, issn 0007-0920, 8 p.Article

Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II studyKOTSAKIS, A; VETSIKA, E.-K; KOSMATOPOULOS, K et al.Annals of oncology. 2012, Vol 23, Num 2, pp 442-449, issn 0923-7534, 8 p.Article

Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II studyKENTEPOZIDIS, N; SOULTATI, A; GIASSAS, S et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 1, pp 161-168, issn 0344-5704, 8 p.Article